2015
Thompson CM, Suh M , Hixon G, Bichteler A. Comparison of smoothing spline regression and conventional modeling approaches for quantitative risk sssessments of human dioxin exposure. Presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.
View Abstract
Topics: dioxin , modeling , risk assessment
2014
Wu C, Fortier KJ, LaPensee K, Fan W, Mitchell M, Cyr PL , Jensen IS . A US hospital economic impact model for oritavancin in ABSSSI patients with risk of MRSA infections. Abstract PSS10 , ISPOR 17th Annual European Congress 2014.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Erichsen R, Kelsh MA , Oliner KS, Nielsen KB, Frøslev T, Lænkholm AV, et al. Prognostic impact of tumor MET expression among patients with stage IV gastric cancer: A Danish cohort study. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Taipei, Taiwan, October 28–30, 2014.
Topics: Cancer
Meddings J, Saint S, Krein S, Gaies E, Reichert H , Hickner A, McNamara S, Mody L. Systematic review of interventions to reduce catheter-associated urinary tract infection in the long-term care setting. Presented at ID Week, Philadelphia, PA, October 2014.
Topics: Systematic Review
Movva N , Babik I, Galloway JC, Lobo MA. Use of an innovative rehabilitation device for infants to improve upper extremity functionality. Poster presentation at the Undergraduate Research and Service Celebratory Symposium, Newark, DE, August 2014.
Topics: Health Economics and Outcomes Research (HEOR)
Jensen IS , Bay C, Cyr PL . Estimating the impact of combining cangrelor and bivalirudin to a U.S. hospital performing PCI procedures. ISPOR 18th Annual International Meeting, New Montreal Quebec, 2014.
Topics: Health Economics and Outcomes Research (HEOR)
Jensen IS , Wu C, Bay CB, Cyr PL . Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.
Topics: Health Economics and Outcomes Research (HEOR)
Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL , Jensen IS . A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.
Topics: Health Economics and Outcomes Research (HEOR)
Bay C, Cyr PL , Jensen IS . Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.
Topics: Health Economics and Outcomes Research (HEOR)
Pinto DS, Nicholson G, Harrington RA, Cyr PL , Bhatt DL. CHAMPION PHOENIX Study economic results: Direct hospitalization costs of patients receiving clopidogrel or cangralor during percutaneous coronary intervention. American Heart Association QCOR conference, Baltimore, MD, 2014.
A Division of